Moderna (NASDAQ:MRNA – Get Rating) and Qiagen (NASDAQ:QGEN – Get Rating) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Insider & Institutional Ownership 61.2% of Moderna shares are owned by […]
Exelixis (NASDAQ:EXEL – Get Rating) and Qiagen (NYSE:QGEN – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Valuation & Earnings This table compares Exelixis and Qiagen’s top-line revenue, earnings […]
Qiagen (NYSE:QGEN – Get Rating) released its quarterly earnings results on Wednesday. The company reported $0.80 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.09, MarketWatch Earnings reports. Qiagen had a net margin of 26.61% and a return on equity of 20.71%. During the same period in the […]
Qiagen (NYSE:QGEN – Get Rating) updated its FY 2022 earnings guidance on Tuesday. The company provided EPS guidance of $2.140-$ for the period. The company issued revenue guidance of $2.12 B-, compared to the consensus revenue estimate of $1.90 billion. QGEN traded down $0.26 during trading on Tuesday, reaching $44.91. 1,069,770 shares of the company’s […]
Equities analysts expect that Qiagen (NYSE:QGEN – Get Rating) will announce sales of $589.95 million for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Qiagen’s earnings, with the highest sales estimate coming in at $590.00 million and the lowest estimate coming in at $589.90 million. Qiagen posted sales of $567.21 million […]